Literature DB >> 29127519

Neutrophil biology within hepatic environment.

Débora Moreira Alvarenga1, Matheus Silvério Mattos1, Alan Moreira Araújo1, Maísa Mota Antunes2, Gustavo Batista Menezes3.   

Abstract

Neutrophils are the most abundant leukocyte in the human circulation. These short-lived cells are constantly produced from hematopoietic stem cells (HSC) within the bone marrow from which they daily reach the blood and perform major roles in innate immunity. Neutrophils are the first cells to reach inflamed tissues and are armed with a plethora of enzymes that help both with their trafficking within tissues and the killing of pathogens. Damaged or infected organs are rapidly invaded by neutrophils. Their erroneous activation within parenchyma or the vasculature is involved in the pathogenesis of several inflammatory diseases including arthritis, colitis, sepsis, acute lung injury and liver failure. Despite the proposal of a canonical pathway that governs neutrophil migration into tissues, the liver has been extensively described as a unique environment for leukocyte recruitment. Since the control of inflammatory responses is considered one of the most promising avenues for novel therapeutics, the expansion of our understanding of the mechanisms behind neutrophil accumulation within injured liver might add to the development of specific and more efficacious treatments. In this review, we discuss the basic concepts of neutrophil ontogeny and biology, with a focus on the particularities and the molecular steps involved in neutrophil recruitment to the liver.

Entities:  

Keywords:  Gastroenterology; Hepatology; Immunology; Liver; Neutrophils

Mesh:

Year:  2017        PMID: 29127519     DOI: 10.1007/s00441-017-2722-9

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  7 in total

Review 1.  Neutrophils as regulators of the hematopoietic niche.

Authors:  Itziar Cossío; Daniel Lucas; Andrés Hidalgo
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

Review 2.  Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity.

Authors:  Hirofumi Hirao; Kojiro Nakamura; Jerzy W Kupiec-Weglinski
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-26       Impact factor: 46.802

3.  Volatile Anesthetic Isoflurane Attenuates Liver Injury in Experimental Polymicrobial Sepsis Model.

Authors:  Sophia Koutsogiannaki; Hui Zha; Koichi Yuki
Journal:  Transl Perioper Pain Med       Date:  2018-05-22

Review 4.  Mesenchymal stromal cell-dependent immunoregulation in chemically-induced acute liver failure.

Authors:  Jia-Hang Zhou; Xuan Lu; Cui-Lin Yan; Xin-Yu Sheng; Hong-Cui Cao
Journal:  World J Stem Cells       Date:  2021-03-26       Impact factor: 5.326

5.  Glucagon Reduces Neutrophil Migration and Increases Susceptibility to Sepsis in Diabetic Mice.

Authors:  Daniella Bianchi Reis Insuela; Maximiliano Ruben Ferrero; Cassiano Felippe Gonçalves-de-Albuquerque; Amanda da Silva Chaves; Adriano Yagho Oliveira da Silva; Hugo Caire Castro-Faria-Neto; Rafael Loureiro Simões; Thereza Christina Barja-Fidalgo; Patricia Machado Rodrigues E Silva; Marco Aurélio Martins; Adriana Ribeiro Silva; Vinicius Frias Carvalho
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

6.  Kupffer cell-derived TNF-α promotes hepatocytes to produce CXCL1 and mobilize neutrophils in response to necrotic cells.

Authors:  Li Su; Na Li; Hua Tang; Ziyang Lou; Xiaodan Chong; Chenxi Zhang; Jiacan Su; Xin Dong
Journal:  Cell Death Dis       Date:  2018-02-23       Impact factor: 8.469

7.  Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.

Authors:  Jinchao Jia; Luyu Yang; Zhujun Cao; Mengyan Wang; Yuning Ma; Xiong Ma; Qiaoyan Liu; Jialin Teng; Hui Shi; Honglei Liu; Xiaobing Cheng; Junna Ye; Yutong Su; Yue Sun; Huihui Chi; Tingting Liu; Zhihong Wang; Liyan Wan; Chengde Yang; Qiongyi Hu
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.